Mayo Clinic in Florida
Jacksonville, Florida, 32224-9980, United States
NCT Number: NCT07126522
This clinical trial studies how well a virtual support platform, the Health Equity Resources for Breast Cancer Responsive Education (HERCaRE) application (app), works in improving survivorship among Black survivors of breast cancer. The HERCaRE platform is a mobile-friendly app that includes culturally tailored educational materials, interactive content, and health equity resources to help patients better understand and manage survivorship after breast cancer treatment. This trial may help improve how digital health interventions can enhance survivorship support and access to resources.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Jacksonville, Florida, 32224-9980, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ancillary studies
Other names: Discuss
Use the HERCaRE app
Ancillary studies
Ancillary studies
Time frame: Up to 6 weeks
Assessed by active use of the Health Equity Resources for Breast Cancer Responsive Education (HERCaRE) platform, defined as number of logins per participant.
Time frame: Up to 6 weeks
Assessed by the length of time each participant spent using the HERCaRE platform.
Time frame: Up to 6 weeks
Assessed by self-reported actions such as initiating conversations with providers or accessing survivorship resources. Information will be obtained through semi-structured interviews.
Time frame: Up to 6 weeks
Assessed by participant self-reported scheduling or completion of appointments (e.g., mammograms, primary care physician visits). Information will be obtained through semi-structured interviews.
Time frame: Up to 6 weeks
Will be assessed by 5 question from a 9-question HERCaRE Final Survey. Three questions are answered on a 5-point scale (strongly agree, agree, neutral, disagree, strongly disagree), and two questions are open-ended/free text.
Time frame: Up to 6 weeks
Will be assessed by a 4 question of a 9-question HERCaRE Final Survey. Two questions are multiple choice (e.g., Yes, No, Not sure) Once is related to likelihood of taking follow-up actions such as "schedule and attend a follow-up appointment" or "ask more questions during my next visit." The final question is an open-ended/free text question related to any difficulties using the app or competing activities.
Mayo Clinic
Other
Advancing Survivorship Support Through Virtual Health Equity Resources for Breast Cancer Responsive Education (HERCaRE)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03180294
Adnexal Diseases, Breast Carcinoma
Anaheim, California, United States
View Trial DetailsNCT05505175
Breast Cancer, Breast Carcinoma
Salvador, Estado de Bahia, Brazil
View Trial DetailsNCT07216274
Breast Carcinoma, Breast Diseases
Rochester, Minnesota, United States
View Trial DetailsNCT03612648
Breast Cancer, Breast Carcinoma
St Louis, Missouri, United States
View Trial Details